Initial Treatment of Hyperthyroidism
Start beta-blockers immediately for symptomatic relief (particularly atenolol or propranolol for cardiac symptoms like tachycardia and tremor), then initiate methimazole as the preferred antithyroid drug while monitoring thyroid function every 2-3 weeks. 1, 2
Immediate Symptomatic Management
- Beta-blockers are the first-line symptomatic treatment and should be started immediately in all patients with hyperthyroidism, especially those with cardiac manifestations such as tachycardia, palpitations, or tremor 1, 2
- Continue beta-blocker therapy until antithyroid medications reduce thyroid hormone levels to the therapeutic range 1
- Beta-blockers provide rapid symptom control while waiting for antithyroid drugs to take effect, which typically requires several weeks 1
Antithyroid Drug Selection
Methimazole is the preferred antithyroid drug for most patients due to:
- Lower risk of major side effects compared to propylthiouracil 3
- Convenient once-daily dosing (10-30 mg as a single daily dose) 3, 4
- Lower cost and better availability 3
Critical Exception - Propylthiouracil Use
Propylthiouracil should be reserved only for specific situations 5:
- First trimester of pregnancy or just prior to conception (propylthiouracil may be the treatment of choice during this period) 1, 5
- Patients who cannot tolerate methimazole 5
- Thyroid storm (due to its additional effect of blocking peripheral T4 to T3 conversion) 5
Warning: Propylthiouracil carries an FDA black box warning for severe liver injury and acute liver failure, including cases requiring liver transplantation and resulting in death 5
Severity-Based Treatment Algorithm
Mild Hyperthyroidism (Grade 1)
- Start beta-blockers for symptomatic relief 2
- Initiate methimazole 1
- Monitor thyroid function every 2-3 weeks 1, 2
Moderate Hyperthyroidism (Grade 2)
- Beta-blocker therapy for symptom control 2
- Consider endocrine consultation 1, 2
- Initiate methimazole with closer monitoring 1
- Provide hydration and supportive care 1
Severe Hyperthyroidism (Grade 3-4) or Thyroid Storm
- Mandatory hospitalization and endocrine consultation 1, 2
- Aggressive management with beta-blockers 1
- High-dose antithyroid drugs 1
- Hydration and supportive care 1
- Consider additional therapies including steroids, saturated solution of potassium iodide (SSKI), or possible surgery 1
Special Clinical Scenario: Thyroiditis
If thyroiditis is the cause, do NOT use antithyroid drugs 1:
- Thyroiditis-induced hyperthyroidism is self-limited and resolves in weeks 1
- Treatment focuses solely on symptom management with beta-blockers 1
- Close monitoring is essential as most patients transition to primary hypothyroidism requiring thyroid hormone replacement 1
Monitoring Protocol
- Initial monitoring: every 2-3 weeks until thyroid function normalizes 1, 2
- Once stable, monitor every 4-6 weeks with dose adjustments based on clinical response and laboratory values 1
- Long-term follow-up is necessary even after successful treatment due to risk of recurrence or development of hypothyroidism 1
Critical Safety Monitoring
Immediately discontinue antithyroid drugs if any of these occur 1, 5:
- Agranulocytosis (fever, chills, sore throat) 1, 5
- Hepatitis (fever, loss of appetite, nausea, vomiting, right upper abdominal pain, dark urine, jaundice) 1, 5
- Vasculitis (skin changes, hematuria, hemoptysis) 1, 5
- Thrombocytopenia 1
Pregnancy Considerations
- Propylthiouracil is preferred during first trimester despite its hepatotoxicity risk 1, 5
- Goal: maintain FT4 in the high-normal range using the lowest possible thioamide dosage 1
- Monitor FT4 or free thyroxine index every 2-4 weeks during pregnancy 1
- Women treated with either propylthiouracil or methimazole can breastfeed safely 1
Duration of Initial Antithyroid Drug Therapy
- Typical course: 12-18 months for Graves' disease with goal of inducing long-term remission 1, 6, 7
- Approximately 50% of patients will relapse after discontinuation, requiring consideration of definitive therapy (radioactive iodine or surgery) 7
- Antithyroid drugs will not cure toxic nodular goiter; definitive therapy should be planned 1, 6